Literature DB >> 21771958

Nonmasslike enhancement at breast MR imaging: the added value of mammography and US for lesion categorization.

Isabelle Thomassin-Naggara1, Isabelle Trop, Jocelyne Chopier, Julie David, Lucie Lalonde, Emile Darai, Roman Rouzier, Serge Uzan.   

Abstract

PURPOSE: To determine the value of adding conventional imaging (mammography and ultrasonography [US]) to nonmasslike enhancement (NMLE) analysis with breast magnetic resonance (MR) imaging for predicting malignancy and for building an interpretation model incorporating all imaging modalities.
MATERIALS AND METHODS: The institutional ethics committees approved the study and granted a waiver of informed consent. In 115 women (mean age, 48.3 years; range, 21-76 years; 56 malignant, 12 high-risk, and 63 benign lesions), 131 NMLE lesions were analyzed. Two independent readers first classified MR images by using descriptive Breast Imaging Reporting and Data System (BI-RADS) criteria (BI-RADS classification with MR images alone [BI-RADS(MR)]) and later repeated this classification, adding information from conventional imaging (BI-RADS classification with combination of MR images and conventional images [BI-RADS(MR+Con)]). Lesion diagnosis was established with surgical histopathologic findings (n = 68), percutaneous biopsy results (n = 25), or 2 years of stability at MR imaging (n = 38). Receiver operating characteristic curves were built to compare BI-RADS(MR) with BI-RADS(MR+Con). A multivariate interpretation model was constructed and validated in a distinct cohort of 44 women.
RESULTS: Values for inter- and intraobserver agreement, respectively, were better for BI-RADS(MR+Con) (κ = 0.847 and 0.937) than for BI-RADS(MR) (κ = 0.748 and 0.861). For both readers, the areas under the receiver operating characteristic curve (AUCs) for diagnosis of malignancy were also superior when BI-RADS(MR+Con) (AUC = 0.91 [reader 1] and 0.93 [reader 2]) was compared with BI-RADS(MR) (AUC = 0.84 [reader 1] and 0.87 [reader 2]) (P < .05). An interpretation model combining conventional imaging with MR imaging criteria showed very good discrimination (AUC = 0.89 [training set] and 0.90 [validating set]).
CONCLUSION: Adding conventional imaging to NMLE lesion characterization at breast MR imaging improved the diagnostic performance of radiologists, and the interpretation model used offers good accuracy with the potential to optimize the reproducibility of NMLE analysis at MR imaging. © RSNA, 2011.

Entities:  

Mesh:

Year:  2011        PMID: 21771958     DOI: 10.1148/radiol.11110190

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  9 in total

1.  A simple scoring system for breast MRI interpretation: does it compensate for reader experience?

Authors:  Maria Adele Marino; Paola Clauser; Ramona Woitek; Georg J Wengert; Panagiotis Kapetas; Maria Bernathova; Katja Pinker-Domenig; Thomas H Helbich; Klaus Preidler; Pascal A T Baltzer
Journal:  Eur Radiol       Date:  2015-10-29       Impact factor: 5.315

2.  The MRI characteristics of non-mass enhancement lesions of the breast: associations with malignancy.

Authors:  Hale Aydin
Journal:  Br J Radiol       Date:  2019-01-29       Impact factor: 3.039

3.  Breast MR biopsy: Pathological and radiological correlation.

Authors:  Chloé Dratwa; Aurélie Jalaguier-Coudray; Jeanne Thomassin-Piana; Julie Gonin; Jocelyne Chopier; Martine Antoine; Isabelle Trop; Emile Darai; Isabelle Thomassin-Naggara
Journal:  Eur Radiol       Date:  2015-10-29       Impact factor: 5.315

4.  Dynamic contrast-enhanced breast magnetic resonance imaging findings that affect the magnetic resonance-directed ultrasound correlation of non-mass enhancement lesions: a single-center retrospective study.

Authors:  Almila Coskun Bilge; Pinar Ilhan Demir; Hale Aydin; Isil Esen Bostanci
Journal:  Br J Radiol       Date:  2022-01-07       Impact factor: 3.629

5.  Intra-individual randomised comparison of gadobutrol 1.0 M versus gadobenate dimeglumine 0.5 M in patients scheduled for preoperative breast MRI.

Authors:  F Pediconi; R Kubik-Huch; B Chilla; C Schwenke; K Kinkel
Journal:  Eur Radiol       Date:  2012-07-15       Impact factor: 5.315

6.  3 Tesla breast MR imaging as a problem-solving tool: Diagnostic performance and incidental lesions.

Authors:  Claudio Spick; Dieter H M Szolar; Klaus W Preidler; Pia Reittner; Katharina Rauch; Peter Brader; Manfred Tillich; Pascal A Baltzer
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

7.  Utility and Diagnostic Performance of Automated Breast Ultrasound System in Evaluating Pure Non-Mass Enhancement on Breast Magnetic Resonance Imaging.

Authors:  Bo Ra Kwon; Jung Min Chang; Soo Yeon Kim; Su Hyun Lee; Sung Ui Shin; Ann Yi; Nariya Cho; Woo Kyung Moon
Journal:  Korean J Radiol       Date:  2020-07-22       Impact factor: 3.500

8.  Non-Mass Enhancements on DCE-MRI: Development and Validation of a Radiomics-Based Signature for Breast Cancer Diagnoses.

Authors:  Yan Li; Zhenlu L Yang; Wenzhi Z Lv; Yanjin J Qin; Caili L Tang; Xu Yan; Yihao H Guo; Liming M Xia; Tao Ai
Journal:  Front Oncol       Date:  2021-09-22       Impact factor: 6.244

9.  Identification of Breast Cancer Using Integrated Information from MRI and Mammography.

Authors:  Shih-Neng Yang; Fang-Jing Li; Yen-Hsiu Liao; Yueh-Sheng Chen; Wu-Chung Shen; Tzung-Chi Huang
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.